Enable Biosciences is a biotech company.
Enable Biosciences is a biotech company making ultrasensitive tests for hiv, type 1 diabetes, and many other diseases. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 19, 2019 | Grant | $1.48M | 1 |
National Institutes of Health
|
— | Detail |
| Jul 31, 2018 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
| Mar 8, 2018 | Grant | $899.62K | 1 |
National Science Foundation
|
— | Detail |
| Jun 22, 2016 | Grant | $269.77K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |
National Science Foundation
|
Yes | Grant |